I think we were whacked so hard because the black box warning was strike two, strike one being the rida failure. Strike three if there is one will be worse. The company needs some victories now, something we can feel good about. Whether that is another molecule, good news about 113, another Pona indication, or something else, it doesn't really matter. Until there is some positive news, the stock will be tossed around like a ship without a sail, riding the waves of an unpredictable market. Harvey needs to address the concerns about Ponatinib first of all, and then to start this new year with a list of reasons as to why we should feel good about staying invested in this company. He is quite capable of this as he has proven repeatedly when interviewed. This next meeting is very important for the company to reduce the anxiety which we have all had since the 20 percent haircut. I look forward to it with great anticipation.